ArticleJournal of translational medicine2025
Analysis of experimental colorectal liver metastases identifies distinct proliferation-independent transcriptional programs in micro- versus macrometastases.
Article in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDistant relapse following surgical removal of primary stage I-III colorectal cancer is caused by the outgrowth of micrometastases that were undetectable at first diagnosis. Adjuvant chemotherapy lowers the risk of distant metastasis formation by only ~15%, indicating that more effective metastasis-prevention strategies are urgently needed. Research aiming to develop such strategies is challenging, due to the low abundance of micrometastases, their small size, and the paucity of model systems.
methodsWe applied a p27-based fluorescent reporter to identify quiescent tumor cells in vitro and in vivo. Colon cancer patient-derived organoids (PDOs) were transplanted into the mouse caecum, which led to spontaneous formation of micro- and macrometastases. Liver metastases were analyzed by immunohistochemistry. In addition, a liver perfusion and collagenase-based homogenization protocol was developed which allows isolation of micro- and macrometastases. Subsequently, p27-positive and p27-negative tumor cells were isolated and analyzed by bulk and single cell RNA sequencing.
resultsIn vitro and in vivo analyses validated the p27-reporter as a robust tool for separating quiescent from cycling tumor cells. In vivo analyses revealed that micrometastases can be either cycling or quiescent in our metastasis model. In depth analyses of quiescent cells obtained from differently sized metastases showed that macrometastases are characterized by TNFα signaling and epithelial-to-mesenchymal transition. By contrast, micrometastases are characterized by upregulation of metabolic pathways including oxidative phosphorylation. Macrometastases, but not micrometastases, are characterized by the presence of cancer-associated fibroblasts and collagen deposition.
conclusionWe developed a strategy to analyze spontaneously formed quiescent micrometastases at single-cell resolution and demonstrate that these lesions form a transcriptionally distinct tumor entity. The data provides leads for developing alternative relapse-prevention strategies that target quiescent micrometastases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.